Warren Chant
|
Master trusts may have outperformed other sectors of the superannuation industry last year, but the latest Chant West data reveals that not-for-profits have continued to dominate the list of top-rated funds.
Chant West principal Warren Chant acknowledged that retail master trusts outperformed industry funds for the first time in four years during 2009. However, he said that while investment was very important and accounted for 40 per cent of his company’s overall methodology, Chant West did not rate funds higher or lower on the basis of just one year’s performance.
He said the reason not-for-profit funds achieved higher ratings was to be found in their overall value proposition.
“The better industry funds have relatively low administration fees, excellent investment processes, low-cost insurance and an increasing range of member services including some excellent member education,” Chant said.
The Chant West analysis listed the top 10 personal super products, in alphabetical order, as being: AGEST, AustralianSuper, CareSuper, Colonial First State FirstChoice Wholesale, First State Super, Hostplus, NGS Super, REST, Sunsuper and UniSuper.
The Chant West data revealed that the top funds for medium-sized corporate super plans were AMP Signature, AustralianSuper Corporate, Mercer, Plum, Russell and Sunsuper Corporate.
Looking purely at investments, the top 10 funds were AustralianSuper, CareSuper, Cbus, First State Super, Hostplus, Mercer, NGS Super, REST, Sunsuper and Unisuper.
Jim Chalmers has defended changes to the Future Fund’s mandate, referring to himself as a “big supporter” of the sovereign wealth fund, amid fierce opposition from the Coalition, which has pledged to reverse any changes if it wins next year’s election.
In a new review of the country’s largest fund, a research house says it’s well placed to deliver attractive returns despite challenges.
Chant West analysis suggests super could be well placed to deliver a double-digit result by the end of the calendar year.
Specific valuation decisions made by the $88 billion fund at the beginning of the pandemic were “not adequate for the deteriorating market conditions”, according to the prudential regulator.